Trends and Outlook in M&A and Partnering
Monday, January 19, 2009
9:15 am - 10:30 am
Grand Ballroom West
This session will focus on the current environment for international, cross-border partnering and M&A and the outlook for 2009. With the current challenging financing environment, corporate investment, partnering and M&A may be one of the few bright spots of activity in 2009. With big pharma pipeline needs and the acute needs for capital among biotechs, 2009 promises to be both a tremendous challenge and a great opportunity for all companies. If you are looking for a strategic transaction, how can you get the attention of the pharma companies? At the pharma companies, how will you develop your priorities and focus your resources to sort through the various opportunities. The panel will include key dealmakers and will discuss their perspectives on the outlook for partnering and M&A activity.
Moderator:
- George G. Montgomery, Co-Founder and Managing Director, Montgomery, Marshall Healthcare Partners, LLC
Panelists:
- Masaki Doi, Executive Officer, Vice President of Business Development, Astellas Pharma Inc.
- Alex Fowkes, Executive Director, Head of R&D Business Development, Asia, Pfizer Global Research & Development
- Scott Koenig, M.D., Ph.D., President and Chief Executive Officer, MacroGenics Inc.
- Tod Woolf, Ph.D., President and CEO, RXi Pharmaceuticals